Citadel Advisors
MNOV icon

Citadel Advisors’s MediciNova MNOV Stock Holding History

Citadel Advisors’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,500
Closed -$41.6K – 14103
2025
Q1 		$41.6K Buy
+28,500
New +$50.4K ﹤0.01% 12506
2024
Q4 		– Sell
-9,400
Closed -$19.7K – 15058
2024
Q3 		$19.7K Buy
9,400
+2,200
+31% +$3.25K ﹤0.01% 12786
2024
Q2 		$10.4K Sell
7,200
-5,300
-42% -$7.42K ﹤0.01% 13088
2024
Q1 		$18.1K Buy
+12,500
New +$17.8K ﹤0.01% 13072
2023
Q3 		– Sell
-900
Closed -$2.07K – 14792
2023
Q2 		$2.07K Sell
900
-3,200
-78% -$7.05K ﹤0.01% 13835
2023
Q1 		$8.86K Sell
4,100
-12,000
-75% -$27.5K ﹤0.01% 13628
2022
Q4 		$33K Buy
+16,100
New +$35.6K ﹤0.01% 12622
2022
Q3 		– Sell
-10,400
Closed -$26K – 13228
2022
Q2 		$26K Buy
+10,400
New +$27.1K ﹤0.01% 12295
2021
Q4 		– Sell
-22,500
Closed -$85K – 14395
2021
Q3 		$85K Sell
22,500
-3,600
-14% -$13.7K ﹤0.01% 13021
2021
Q2 		$111K Buy
26,100
+9,000
+53% +$38.8K ﹤0.01% 12821
2021
Q1 		$86K Sell
17,100
-2,100
-11% -$12.2K ﹤0.01% 12593
2020
Q4 		$101K Buy
19,200
+7,300
+61% +$41.8K ﹤0.01% 10219
2020
Q3 		$62K Sell
11,900
-3,800
-24% -$21.9K ﹤0.01% 9522
2020
Q2 		$85K Buy
+15,700
New +$83.2K ﹤0.01% 9080
2018
Q4 		– Sell
-12,000
Closed -$150K – 9525
2018
Q3 		$150K Sell
12,000
-1,900
-14% -$19.1K ﹤0.01% 8394
2018
Q2 		$111K Buy
13,900
+2,000
+17% +$20.7K ﹤0.01% 8191
2018
Q1 		$122K Buy
+11,900
New +$119K ﹤0.01% 7643
2017
Q1 		– Sell
-11,500
Closed -$69K – 7817
2016
Q4 		$69K Sell
11,500
-200
-2% -$1.41K ﹤0.01% 6789
2016
Q3 		$88K Buy
+11,700
New +$78.8K ﹤0.01% 6694

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citadel Advisors's MNOV Position: Q1 2026 in Review

Citadel Advisors sold out of MediciNova (MNOV) in Q1 2026, closing a stake of 28,712 shares — an estimated $37.6K sold.

Citadel Advisors first reported a position in MNOV in Q2 2014 and held it in 22 quarters. The position peaked at $364K in Q2 2019. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

  • Citadel Advisors reported no remaining MediciNova position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 28,712 MediciNova shares in Q1 2026, an estimated $37.6K.
  • Citadel Advisors first reported a position in MediciNova in Q2 2014 and held it in 22 quarters.
  • Citadel Advisors's MediciNova position peaked at $364K in Q2 2019.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.